SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
70 hedge funds and large institutions have $105M invested in Syros Pharmaceuticals, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
7% less funds holding
Funds holding: 75 → 70 (-5)
29% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 17
Holders
70
Holding in Top 10
2
Calls
$144K
Puts
$17K
Top Buyers
| 1 | +$821K | |
| 2 | +$561K | |
| 3 | +$532K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$402K |
| 5 |
PCM
Prelude Capital Management
New York
|
+$208K |
Top Sellers
| 1 | -$1.25M | |
| 2 | -$1.02M | |
| 3 | -$951K | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$795K |
| 5 |
Jane Street
New York
|
-$688K |